Overview

Neoadjuvant Letrozole and Palbociclib in Patients With Stage II-IIIB Breast Cancer, HR+, HER2 -

Status:
Completed
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
This is an international, multicenter, open-label, non-comparative, Simon´s two-stage design, phase II clinical trial.
Phase:
Phase 2
Details
Lead Sponsor:
MedSIR
Collaborator:
Pfizer
Treatments:
Letrozole
Palbociclib